SEARCH
Quotes News NAV
Balance Sheet Markets  >  Corporate Information  >   Balance Sheet
Goldline Pharmaceutical Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544759 INE1CLW01015 20.99625 Not Listed 0 44.29 0 0 10
      ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
SOURCES OF FUNDS :   
Share Capital 8.714.113.81
Reserves Total 1.653.762.08
Equity Share Warrants0.000.000.00
Equity Application Money0.000.000.00
Total Shareholders Funds10.367.875.89
Secured Loans 6.677.156.90
Unsecured Loans 4.373.983.93
Total Debt11.0411.1310.83
Other Liabilities0.880.790.68
Total Liabilities22.2819.7917.40
APPLICATION OF FUNDS :   
Gross Block 3.713.522.92
Less : Accumulated Depreciation 0.820.570.42
Less:Impairment of Assets0.000.000.00
Net Block 2.892.952.50
Lease Adjustment0.000.000.00
Capital Work in Progress0.000.450.00
Producing Properties0.000.000.00
Investments 0.040.030.07
Current Assets, Loans & Advances   
Inventories 6.787.495.37
Sundry Debtors 10.699.628.63
Cash and Bank Balance1.240.790.05
Loans and Advances 4.641.602.77
Total Current Assets23.3519.5016.82
Less : Current Liabilities and Provisions   
Current Liabilities 2.872.381.81
Provisions 1.060.700.17
Total Current Liabilities & Provisions3.923.081.98
Net Current Assets19.4316.4214.85
Miscellaneous Expenses not written off 0.000.000.00
Deferred Tax Assets0.000.000.00
Deferred Tax Liability0.090.060.01
Net Deferred Tax-0.09-0.06-0.01
Other Assets0.000.000.00
Total Assets22.2719.7917.41
Contingent Liabilities0.000.000.00